Bolt Biotherapeutics, Inc. (BOLT)
4.67
+0.24
(+5.42%)
USD |
NASDAQ |
Jun 11, 15:12
Bolt Biotherapeutics 1 Year Total Returns (Daily) : -33.30% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -33.30% |
| June 09, 2026 | -24.76% |
| June 08, 2026 | -26.94% |
| June 05, 2026 | -23.49% |
| June 04, 2026 | -26.50% |
| June 03, 2026 | -23.72% |
| June 02, 2026 | -16.37% |
| June 01, 2026 | -15.61% |
| May 29, 2026 | -16.40% |
| May 28, 2026 | -12.08% |
| May 27, 2026 | -17.42% |
| May 26, 2026 | -20.34% |
| May 22, 2026 | -23.85% |
| May 21, 2026 | -27.60% |
| May 20, 2026 | -30.09% |
| May 19, 2026 | -27.98% |
| May 18, 2026 | -25.60% |
| May 15, 2026 | -24.61% |
| May 14, 2026 | -28.57% |
| May 13, 2026 | -30.04% |
| May 12, 2026 | -35.41% |
| May 11, 2026 | -34.36% |
| May 08, 2026 | -36.89% |
| May 07, 2026 | -35.35% |
| May 06, 2026 | -34.05% |
| Date | Value |
|---|---|
| May 05, 2026 | -32.68% |
| May 04, 2026 | -28.43% |
| May 01, 2026 | -27.92% |
| April 30, 2026 | -32.45% |
| April 29, 2026 | -32.00% |
| April 28, 2026 | -34.63% |
| April 27, 2026 | -36.41% |
| April 24, 2026 | -37.92% |
| April 23, 2026 | -35.89% |
| April 22, 2026 | -25.35% |
| April 21, 2026 | -26.83% |
| April 20, 2026 | -26.43% |
| April 17, 2026 | -32.43% |
| April 16, 2026 | -27.56% |
| April 15, 2026 | -28.84% |
| April 14, 2026 | -35.95% |
| April 13, 2026 | -28.02% |
| April 10, 2026 | -23.52% |
| April 09, 2026 | -33.48% |
| April 08, 2026 | -25.81% |
| April 07, 2026 | -31.97% |
| April 06, 2026 | -31.53% |
| April 02, 2026 | -46.51% |
| April 01, 2026 | -41.12% |
| March 31, 2026 | -49.50% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sangamo Therapeutics, Inc. | -71.08% |
| Arrowhead Pharmaceuticals, Inc. | 316.8% |
| Oncolytics Biotech, Inc. | 87.38% |
| Sarepta Therapeutics, Inc. | -61.33% |
| Anixa Biosciences, Inc. | -32.66% |